On 3rd and 4th February 2022, the CRASH organised a workshop aimed at the leaders, operational managers and members of MSF France, to shed light on the current debates on access to medicines, and to determine together which issues are the most relevant to resolve. In preparation for this workshop, the CRASH asked experts external to MSF to explain their vision of today’s pharmaceutical industry system, with subjects that ranged from pre-development to distribution, and included patents and quality-related issues.

This article was first released in the 18th volume of the Humanitarian Alternatives magazine. Designed to reduce the incidence of HIV/AIDS in a Kenyan district, a Médecins Sans Frontières project successfully exceeded the “90-90-90” target set by UNAIDS. A look back on the results that the authors of this article - Pierre Mendiharat, Deputy director of operations at MSF France and Léon Salumu Luzinga, Program manager at MSF France, interviewed by Elba Rahmouni - believe are encouraging but by no means a guarantee that the epidemic will be over by 2030.

This study, conducted among the men of Homa Bay in Nyanza Province, Kenya, assesses the representations of HIV and impact on care seeking. It reveals that simply setting up a testing or care campaign does not necessarily mean that the entire population will participate; the message has to be tailored to the target population and fine-tuned even within that population.

To address the political, economic and legal barriers to patients' access to life-saving treatments, MSF created, in 1999, the Access Campaign (the Campaign for Access to Essential Medicines). In these videos, Jean-Hervé Bradol, doctor and crash study director, answers questions from Andrea Bussotti (MSF-France Operational Communication Manager). In the light of the historical background of the early days of the Access Campaign, he analyses the medico-operational context of the Campaign today and asks himself the question of its objectives.

The study The Patient Perspective of Quality of Care: A Review of the Literature, which we present here was carried out by Hannah Barnett a public health student at George Washington University, intern with CRASH from June to August 2018. This work sums up seventy articles from a variety of disciplines including medicine and public health. It is part of a reflection initiated by MSF a few years ago on medical quality and the patient-centered approach.

Michaël Neuman's review of "Medical Humanitarianism: Ethnographies of practice" edited by Sharon Abramowitz and Catherine Panter-Brick (Philadelphia: University of Pennsylvania Press, 2015)

The question of quality in the work of Médecins Sans Frontières has been asked from the very beginning of MSF's existence. On the one hand, the issue of improving the quality of practice is a part of ordinary professional activity; on the other hand, Médecins Sans Frontières' work involved working in distant lands and very specific environments, which demanded adjustments to medical practice as a result.

The Drugs for Neglected Diseases initiative (DNDi) and other researchers, including MSF-Crash Dr. Jean Hervé Bradol, report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts. 

Our survey bears something of a resemblance to a study carried out by Vanja Kovacic in Homa Bay, Kenya, in which she investigated patients’ disease coping mechanisms and their “dependence on medical institutions”.